Sortina Pharma

The Sortina´s mission is to create a platform of life-saving world-class small molecule therapeutics targeting sortilin. Focusing on critical diseases such as cancer and neurodegenerative conditions where sortilin overexpression or dysfunction has been linked to disease progression. In-house development of a first in class cancer drug, starting with Glioblastoma Multiforme, followed by consecutive inclusion of additional cancer forms and parallel optimization of unique small molecules for neurodegenerative diseases and beyond.